Anika Therapeutics - 27 Year Stock Price History | ANIK

Historical daily share price chart and data for Anika Therapeutics since 1993 adjusted for splits. The latest closing stock price for Anika Therapeutics as of April 07, 2020 is 28.11.
  • The all-time high Anika Therapeutics stock closing price was 73.36 on October 25, 2019.
  • The Anika Therapeutics 52-week high stock price is 75.72, which is 169.4% above the current share price.
  • The Anika Therapeutics 52-week low stock price is 22.01, which is 21.7% below the current share price.
  • The average Anika Therapeutics stock price for the last 52 weeks is 46.82.
Anika Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 39.5680 52.4000 54.0600 22.3800 28.1100 -45.79%
2019 45.1985 34.5200 73.3600 29.3700 51.8500 54.27%
2018 43.2097 54.9100 68.4300 28.7700 33.6100 -37.66%
2017 50.3632 50.1100 59.9400 41.7200 53.9100 10.11%
2016 45.8884 38.0800 54.2600 35.3000 48.9600 28.30%
2015 37.2732 39.7600 45.2100 31.3500 38.1600 -6.33%
2014 41.0168 34.9900 50.4300 29.4800 40.7400 6.76%
2013 20.0087 10.8700 38.1600 10.2200 38.1600 283.90%
2012 12.7090 9.3100 17.5400 9.0800 9.9400 1.43%
2011 7.5280 6.7300 11.1700 5.3300 9.8000 46.93%
2010 6.2777 7.5600 7.9000 4.9500 6.6700 -12.58%
2009 5.6700 3.1200 9.0500 3.0500 7.6300 150.99%
2008 8.3621 15.1800 15.1800 3.0000 3.0400 -79.11%
2007 15.4437 13.1700 21.8000 12.3100 14.5500 9.65%
2006 11.9701 11.5400 14.7400 9.5000 13.2700 13.52%
2005 12.1348 9.0000 17.0000 8.1000 11.6900 27.76%
2004 11.4183 9.3600 17.5300 6.8000 9.1500 -6.06%
2003 4.1682 1.0400 11.5000 0.9900 9.7400 883.84%
2002 1.1214 1.1000 1.3900 0.8500 0.9900 -1.00%
2001 1.1379 0.8125 1.6880 0.8125 1.0000 27.99%
2000 4.2242 7.0000 11.5000 0.7500 0.7813 -88.94%
1999 5.9460 5.0630 8.6880 4.5000 7.0630 31.40%
1998 10.2554 8.6250 18.1900 3.9380 5.3750 -42.28%
1997 6.7512 3.8750 10.5000 3.8750 9.3130 148.35%
1996 4.7312 3.8800 7.5000 3.4400 3.7500 -3.23%
1995 2.5569 1.8750 3.8750 1.6200 3.8750 106.67%
1994 2.7154 4.0310 4.1250 1.5000 1.8750 -58.04%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.412B $0.115B
Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $124.791B 14.27
Gilead Sciences (GILD) United States $97.863B 12.66
CSL (CSLLY) Australia $90.292B 0.00
Vertex Pharmaceuticals (VRTX) United States $66.191B 60.07
Regeneron Pharmaceuticals (REGN) United States $55.479B 23.50
Biogen (BIIB) United States $54.202B 9.26
Illumina (ILMN) United States $40.867B 42.25
Seattle Genetics (SGEN) United States $21.467B 0.00
Alexion Pharmaceuticals (ALXN) United States $21.302B 9.88
Incyte (INCY) United States $18.450B 39.59
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.892B 636.69
Genmab (GMAB) Denmark $14.017B 10.88
Galapagos (GLPG) Belgium $13.121B 40.10
Genmab (GNMSF) Denmark $13.109B 42.16
Alnylam Pharmaceuticals (ALNY) United States $12.680B 0.00
BioNTech SE (BNTX) Germany $11.931B 0.00
Moderna (MRNA) United States $11.397B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.292B 52.78
BeiGene (BGNE) Cayman Islands $9.396B 0.00
Exact Sciences (EXAS) United States $9.214B 0.00
QIAGEN (QGEN) Netherlands $9.110B 27.78
Sarepta Therapeutics (SRPT) United States $7.861B 0.00
Bio-Techne Corp (TECH) United States $7.461B 51.06
ACADIA Pharmaceuticals (ACAD) United States $6.725B 0.00
Guardant Health (GH) United States $6.323B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.077B 16.06
ARGENX SE-ADR (ARGX) Netherlands $5.853B 0.00
Ascendis Pharma (ASND) Denmark $5.649B 0.00
Exelixis (EXEL) United States $5.396B 17.32
Repligen (RGEN) United States $5.245B 95.91
Acceleron Pharma (XLRN) United States $4.652B 0.00
Reata Pharmaceuticals (RETA) United States $4.595B 0.00
Vir Biotechnology (VIR) United States $4.030B 0.00
Immunomedics (IMMU) United States $4.018B 0.00
China Biologic Products (CBPO) China $3.903B 23.17
Adaptive Biotechnologies (ADPT) United States $3.550B 0.00
Blueprint Medicines (BPMC) United States $3.546B 0.00
Global Blood Therapeutics (GBT) United States $3.492B 0.00
Mirati Therapeutics (MRTX) United States $3.433B 0.00
MorphoSys AG (MOR) Germany $3.340B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.284B 0.00
Emergent Biosolutions (EBS) United States $3.190B 22.14
Zai Lab (ZLAB) China $3.047B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.979B 0.00
NeoGenomics (NEO) United States $2.747B 119.09
CRISPR Therapeutics AG (CRSP) Switzerland $2.568B 43.47
Amicus Therapeutics (FOLD) United States $2.531B 0.00
Bluebird Bio (BLUE) United States $2.411B 0.00
Alkermes (ALKS) Ireland $2.390B 189.38
Halozyme Therapeutics (HALO) United States $2.383B 0.00
Arena Pharmaceuticals (ARNA) United States $2.379B 6.20
Deciphera Pharmaceuticals (DCPH) United States $2.350B 0.00
MyoKardia (MYOK) United States $2.238B 0.00
UniQure (QURE) Netherlands $2.116B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.065B 0.00
Denali Therapeutics (DNLI) United States $1.976B 0.00
Principia Biopharma (PRNB) United States $1.914B 0.00
Fate Therapeutics (FATE) United States $1.883B 0.00
Alector (ALEC) United States $1.840B 0.00
Amarin (AMRN) Ireland $1.715B 0.00
Eidos Therapeutics (EIDX) United States $1.690B 0.00
Arvinas (ARVN) United States $1.664B 0.00
Zymeworks (ZYME) Canada $1.646B 0.00
Insmed (INSM) United States $1.597B 0.00
Akcea Therapeutics (AKCA) United States $1.592B 34.24
Viela Bio (VIE) United States $1.556B 0.00
Epizyme (EPZM) United States $1.540B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.461B 0.00
Ligand Pharmaceuticals (LGND) United States $1.278B 39.71
Inovio Pharmaceuticals (INO) United States $1.230B 0.00
Zealand Pharma (ZEAL) Denmark $1.187B 0.00
Editas Medicine (EDIT) United States $1.172B 0.00
Myriad Genetics (MYGN) United States $1.142B 20.16
Coherus BioSciences (CHRS) United States $1.126B 13.40
REGENXBIO (RGNX) United States $1.117B 0.00
PHARMA MAR SA (PHMMF) Spain $1.107B 0.00
Twist Bioscience (TWST) United States $1.054B 0.00
NextCure (NXTC) United States $1.032B 0.00
NGM Biopharmaceuticals (NGM) United States $0.908B 0.00
Revance Therapeutics (RVNC) United States $0.887B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Intra-Cellular Therapies (ITCI) United States $0.858B 0.00
Beam Therapeutics (BEAM) United States $0.855B 0.00
Novavax (NVAX) United States $0.830B 0.00
Adverum Biotechnologies (ADVM) United States $0.794B 0.00
I-Mab (IMAB) China $0.787B 0.00
Sangamo Therapeutics (SGMO) United States $0.787B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.756B 0.00
Cytokineticsorporated (CYTK) United States $0.741B 0.00
Arcus Biosciences (RCUS) United States $0.717B 0.00
Retrophin (RTRX) United States $0.694B 0.00
Bellus Health (BLU) Canada $0.671B 0.00
Athenex (ATNX) United States $0.664B 0.00
Pharming Group (PHGUF) Netherlands $0.663B 0.00
Mesoblast (MESO) Australia $0.662B 0.00
GENFIT S.A (GNFT) France $0.661B 0.00
Cara Therapeutics (CARA) United States $0.626B 0.00
Kadmon Holdings (KDMN) United States $0.622B 0.00
Intellia Therapeutics (NTLA) United States $0.621B 0.00
Codexis (CDXS) United States $0.616B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.589B 5.18
Compugen (CGEN) Israel $0.556B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.556B 0.00
ANI Pharmaceuticals (ANIP) United States $0.523B 9.44
Castle Biosciences (CSTL) United States $0.519B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.513B 0.00
Intrexon (PGEN) United States $0.504B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.500B 0.00
Clovis Oncology (CLVS) United States $0.499B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.497B 0.00
MeiraGTx Holdings (MGTX) United States $0.497B 0.00
AC Immune SA (ACIU) Switzerland $0.489B 12.48
Frequency Therapeutics (FREQ) United States $0.487B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.484B 0.00
Prothena (PRTA) Ireland $0.474B 0.00
Sorrento Therapeutics (SRNE) United States $0.473B 0.00
Athersys (ATHX) United States $0.463B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Morphic Holding (MORF) United States $0.457B 0.00
Heska (HSKA) United States $0.439B 0.00
Scholar Rock Holding (SRRK) United States $0.432B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.424B 0.00
Verastem (VSTM) United States $0.420B 0.00
UROGEN PHARMA (URGN) United States $0.419B 0.00
AnaptysBio (ANAB) United States $0.416B 0.00
Vericel (VCEL) United States $0.414B 61.33
DBV Technologies S.A (DBVT) France $0.413B 0.00
Cel-Sci (CVM) United States $0.409B 0.00
Agenus (AGEN) United States $0.399B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.390B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.382B 0.00
BioDelivery Sciences (BDSI) United States $0.381B 43.89
Cue Biopharma (CUE) United States $0.381B 0.00
MiMedx (MDXG) United States $0.378B 0.00
Cellectis S.A (CLLS) France $0.376B 0.00
CytomX Therapeutics (CTMX) United States $0.364B 0.00
PDL BioPharma (PDLI) United States $0.351B 10.52
Kala Pharmaceuticals (KALA) United States $0.342B 0.00
Merus (MRUS) Netherlands $0.334B 0.00
Pfenex (PFNX) United States $0.306B 446.50
Syndax Pharmaceuticals (SNDX) United States $0.302B 0.00
Puma Biotechnology (PBYI) United States $0.300B 0.00
Syros Pharmaceuticals (SYRS) United States $0.299B 0.00
Cellular Biomedicine (CBMG) United States $0.299B 0.00
NantKwest (NK) United States $0.295B 0.00
Precision BioSciences (DTIL) United States $0.292B 0.00
WAVE Life Sciences (WVE) Singapore $0.289B 0.00
Dynavax Technologies (DVAX) United States $0.280B 0.00
ADMA Biologics Inc (ADMA) United States $0.275B 0.00
Avid Bioservices (CDMO) United States $0.271B 0.00
Kamada (KMDA) Israel $0.269B 11.20
Autolus Therapeutics (AUTL) United Kingdom $0.255B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.250B 0.00
Gritstone Oncology (GRTS) United States $0.246B 0.00
Mersana Therapeutics (MRSN) United States $0.244B 0.00
Stemline Therapeutics (STML) United States $0.240B 0.00
Albireo Pharma (ALBO) United States $0.238B 0.00
Seres Therapeutics (MCRB) United States $0.236B 0.00
Aduro Biotech (ADRO) United States $0.232B 0.00
Sutro Biopharma (STRO) United States $0.229B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.229B 0.00
Geron (GERN) United States $0.224B 0.00
ChromaDex (CDXC) United States $0.209B 0.00
MannKind (MNKD) United States $0.209B 0.00
Starpharma Holdings (SPHRY) Australia $0.201B 0.00
Alcobra (ARCT) United States $0.200B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.199B 1.79
XOMA (XOMA) United States $0.197B 0.00
Abeona Therapeutics (ABEO) United States $0.191B 0.00
Prometic Life Sciences (LMNL) Canada $0.184B 0.00
Protagonist Therapeutics (PTGX) United States $0.183B 0.00
HOOKIPA Pharma (HOOK) United States $0.181B 0.00
VBI Vaccines (VBIV) United States $0.178B 0.00
IVERIC Bio (ISEE) United States $0.170B 0.00
Selecta Biosciences (SELB) United States $0.169B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.163B 0.00
Spero Therapeutics (SPRO) United States $0.162B 0.00
OSMOTICA PHARM (OSMT) United States $0.161B 0.00
Kindred Biosciences (KIN) United States $0.160B 0.00
Liquidia Technologies (LQDA) United States $0.159B 0.00
Fortress Biotech (FBIO) United States $0.157B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.152B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Dyadic (DYAI) United States $0.144B 0.00
Aytu Bioscience (AYTU) United States $0.143B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.141B 0.00
Affimed (AFMD) Germany $0.139B 0.00
VolitionRX (VNRX) United States $0.138B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
Cerecor (CERC) United States $0.135B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Biofrontera AG (BFRA) Germany $0.133B 0.00
Theratechnologies (THTX) Canada $0.129B 0.00
Antibe Therapeutics (ATBPF) Canada $0.127B 0.00
Exicure (XCUR) United States $0.123B 0.00
AIT Therapeutics (XAIR) United States $0.122B 0.00
VTv Therapeutics (VTVT) United States $0.121B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.118B 4.64
Northwest Biotherapeutics (NWBO) United States $0.105B 0.00
Strongbridge Biopharma (SBBP) United States $0.105B 0.00
Celyad SA (CYAD) Belgium $0.103B 0.00
Palatin Technologies (PTN) United States $0.100B 2.73
Cidara Therapeutics (CDTX) United States $0.099B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.098B 0.00
Aptinyx (APTX) United States $0.098B 0.00
TELA Bio (TELA) United States $0.091B 0.00
ARAVIVE, INC (ARAV) United States $0.089B 0.00
IBio (IBIO) United States $0.089B 0.00
CorMedix Inc (CRMD) United States $0.088B 0.00
PHASEBIO PHARMA (PHAS) United States $0.086B 0.00
Five Prime Therapeutics (FPRX) United States $0.086B 0.00
Happiness Biotech Group (HAPP) China $0.085B 0.00
Arbutus Biopharma (ABUS) Canada $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.072B 0.00
Cyclerion Therapeutics (CYCN) United States $0.071B 0.00
Clearside Biomedical (CLSD) United States $0.070B 0.00
Orgenesis (ORGS) United States $0.070B 4.11
Checkpoint Therapeutics (CKPT) United States $0.068B 0.00
Adocia (ADOCY) France $0.066B 0.00
Eton Pharmaceuticals (ETON) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.063B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
Emmaus Life Sciences (EMMA) United States $0.061B 0.00
Proteostasis Therapeutics (PTI) United States $0.060B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
SESEN BIO, INC (SESN) United States $0.059B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.057B 0.00
Synlogic (SYBX) United States $0.057B 0.00
AquaBounty Technologies (AQB) United States $0.054B 0.00
Catalyst Biosciences (CBIO) United States $0.052B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.050B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.050B 0.00
Trevena (TRVN) United States $0.048B 0.00
Stealth BioTherapeutics (MITO) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
Acorda Therapeutics (ACOR) United States $0.045B 0.00
Idera Pharmaceuticals (IDRA) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.039B 0.00
Cocrystal Pharma (COCP) United States $0.038B 0.00
Advaxis (ADXS) United States $0.038B 0.00
Soligenix (SNGX) United States $0.037B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.036B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
Menlo Therapeutics (MNLO) United States $0.034B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
CollPlant Holdings (CLGN) Israel $0.033B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.033B 0.00
Celldex Therapeutics (CLDX) United States $0.031B 0.00
Prima BioMed (IMMP) Australia $0.027B 0.00
Pulmatrix (PULM) United States $0.027B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
OvaScience (MLND) United States $0.026B 0.00
Celsion (CLSN) United States $0.026B 0.00
Evogene (EVGN) Israel $0.025B 0.00
ATyr Pharma (LIFE) United States $0.025B 0.00
TOCAGEN INC (TOCA) United States $0.025B 0.00
Curis (CRIS) United States $0.024B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
BioCardia (BCDA) United States $0.020B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
Alimera Sciences (ALIM) United States $0.019B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Stellar Biotechnologies (EDSA) Canada $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Oncobiologics (OTLK) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.017B 0.00
Cesca Therapeutics (THMO) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
VIVUS (VVUS) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Aptevo Therapeutics (APVO) United States $0.011B 0.00
Unum Therapeutics (UMRX) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
TrovaGene (TROV) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00